How have LXG shares performed in 2024?

LexaGene's stock was trading at C$0.11 on January 1st, 2024. Since then, LXG shares have increased by 0.0% and is now trading at C$0.11. View the best growth stocks for 2024 here .

What other stocks do shareholders of LexaGene own?

Based on aggregate information from My MarketBeat watchlists, some companies that other LexaGene investors own include Jaguar Mining (JAG) , Northern Superior Resources (SUP) , Vaccinex (VCNX) , Gevo (GEVO) , HIVE Digital Technologies (HIVE) , EQT (EQT) , Freehold Royalties (FRU) , GFG Resources (GFG) and IAMGOLD (IMG) .

How do I buy shares of LexaGene?

Shares of LXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor , Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. Compare Top Brokerages Here .

CVE:LXG

LexaGene (LXG) Stock Price, News & Analysis

→ Could Bitcoin Literally FORCE This Crypto To Rocket Up? (From Paradigm Press) (Ad)

Free LXG Stock Alerts

C$0.10

-0.03 (-19.23%)

(As of 02/21/2023)

Compare

Today's Range: C$0.10
▼
C$0.14
50-Day Range: C$0.11
▼
C$0.11
52-Week Range: C$0.07
▼
C$0.31

Volume: 2.14 million shs
Average Volume: 170,061 shs
Market Capitalization: C$14.77 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get LexaGene alerts:

Ad Market Moving Trends

Top 5 AI Stocks to Buy for 2024

5 Best AI Stocks to Invest In Investors are getting very rich in AI stocks right now. Wall Street legend is giving away the name and ticker of the little-known AI stock Wall Street is currently buying hand-over-fist.

Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"

About LexaGene Stock (CVE:LXG)

LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection. The company was incorporated in 2007 and is headquartered in Beverly, Massachusetts.

LXG Stock Price History

30 days | 90 days | 365 days | Advanced Chart

LXG Stock News Headlines

April 9, 2024 | lse.co.uk

Pamapol Ord Share Price (0LXG)

November 12, 2023 | morningstar.com

Biosynex SA ALBIO

April 17, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

October 31, 2023 | morningstar.com

Cyclopharm Ltd CYC

October 16, 2023 | investing.com

Lexagene Holdings Inc (LXGh)

September 2, 2023 | morningstar.com

Eurobio Scientific Bearer and/or Registered shares issued from reverse spli

July 28, 2023 | morningstar.com

Zhejiang Gongdong Medical Technology Co Ltd Class A

February 22, 2023 | finance.yahoo.com

IIROC Trading Halt - LXG

April 17, 2024 | Paradigm Press (Ad)

Could Bitcoin Literally FORCE This Crypto To Rocket Up?

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

October 20, 2022 | marketscreener.com

LexaGene Says Large Biopharma Co Engages It in Statement of Work to Expedite Technology Validation - Marketscreener.com

October 20, 2022 | globenewswire.com

Large Biopharma Company Engages LexaGene in Statement of Work to Expedite Technology Validation - GlobeNewswire

October 19, 2022 | streetinsider.com

Form 10-Q LexaGene Holdings Inc. For: Aug 31 - StreetInsider.com

October 13, 2022 | marketscreener.com

LexaGene Rises 23% as Says Got Signed Quote from Large Biopharma Company to Buy a MiQLab System - Marketscreener.com

October 13, 2022 | marketscreener.com

LexaGene Says Received Signed Quote from Large Biopharma Company to Buy a MiQLab System - Marketscreener.com

October 13, 2022 | globenewswire.com

LexaGene Receives Signed Quote from Large Biopharma Company to Purchase a MiQLab System - GlobeNewswire

October 4, 2022 | businesswire.com

Veterinary Infectious Disease Diagnostics Global Market Report 2022: Increasing Incidence of Transboundary and Zoonotic Diseases Drives Growth - ResearchAndMarkets.com - Business Wire

September 1, 2022 | financialpost.com

LexaGene Announces MiQLab® System Sale to Veterinary Hospital in California - Financial Post

September 1, 2022 | gurufocus.com

LexaGene Announces MiQLab® Sys - GuruFocus.com

September 1, 2022 | benzinga.com

LEXAGENE HLDGS INC ORD by Lexagene Hldgs Inc. (LXXGF), (TSXV:LXG) – LexaGene Announces MiQLab® System Sal - Benzinga

August 29, 2022 | globenewswire.com

LexaGene Verifies CDC Monkeypox Assay Works on MiQLab System and Readies Company Should an EUA be Declared - GlobeNewswire

August 24, 2022 | globenewswire.com

LexaGene's MiQLab System Generates Leptospira Results in as - GlobeNewswire

August 23, 2022 | marketscreener.com

LexaGene : OTCQB Cert - Marketscreener.com

August 17, 2022 | marketscreener.com

LexaGene Says U of Penn's School of Veterinary Medicine to Evaluate New Gastrointestinal Panel With MiQLab System - Marketscreener.com

August 17, 2022 | globenewswire.com

University of Pennsylvania's School of Veterinary Medicine - GlobeNewswire

August 10, 2022 | globenewswire.com

LexaGene Reduces Time-to-Result by ~35% - GlobeNewswire

August 9, 2022 | streetinsider.com

Form 10-12G/A LexaGene Holdings Inc. - StreetInsider.com

August 3, 2022 | finance.yahoo.com

Rising Transboundary And Zoonotic Disease Cases Are Fueling The Growth Of The Veterinary Infectious Disease Diagnostics Market As Per The Business Research Company's Veterinary Infectious Disease Diagnostics Global Market Report 2022 - Yahoo Finance

See More Headlines

Receive LXG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for LexaGene and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: CVE
Sector: Medical
Industry: Diagnostics & Research
Sub-Industry: N/A
Current Symbol: CVE:LXG
CUSIP: N/A
CIK: N/A
Web: www.lexagene.com
Phone: 800-215-1824
Fax: N/A
Employees: 41
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): C($0.08)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: C$-8,540,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -339.54%
Return on Assets: -120.21%

Debt

Debt-to-Equity Ratio: 138.01
Current Ratio: 1.39
Quick Ratio: 1.13

Sales & Book Value

Annual Sales: C$110,927.00
Price / Sales: 133.13
Cash Flow: C$0.00 per share
Price / Cash Flow: 21.25
Book Value: C$0.01 per share
Price / Book: 10.50

Miscellaneous

Outstanding Shares: 140,640,000
Free Float: N/A
Market Cap: C$14.77 million
Optionable: Not Optionable
Beta: 2.26

The 10 Best AI Stocks to Own in 2024

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

Dr. John F. Regan (Age 50)
Founder, Chairman & CEO
Comp: $371.68k
Mr. Jeffrey Mitchell (Age 51)
CFO, Treasurer & Corp. Sec.
Comp: $293.4k
Mr. Steven Armstrong (Age 57)
Chief Operating Officer
Comp: $234.32k
Mr. Allan John Fabbro (Age 65)
VP of Corp. Devel.
Nicole Ridgedale
Director of Corp. Marketing
Mr. Jay Adelaar
VP of Capital Markets

Key Competitors

View All Competitors

LXG Stock Analysis - Frequently Asked Questions

How have LXG shares performed in 2024?: LexaGene's stock was trading at C$0.11 on January 1st, 2024. Since then, LXG shares have increased by 0.0% and is now trading at C$0.11.
View the best growth stocks for 2024 here.
What other stocks do shareholders of LexaGene own?: Based on aggregate information from My MarketBeat watchlists, some companies that other LexaGene investors own include Jaguar Mining (JAG), Northern Superior Resources (SUP), Vaccinex (VCNX), Gevo (GEVO), HIVE Digital Technologies (HIVE), EQT (EQT), Freehold Royalties (FRU), GFG Resources (GFG) and IAMGOLD (IMG).
How do I buy shares of LexaGene?: Shares of LXG stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:LXG) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial